FR2338M - Nouveaux remedes destinés notamment au traitement des céphalées d'origine vasculaire. - Google Patents

Nouveaux remedes destinés notamment au traitement des céphalées d'origine vasculaire.

Info

Publication number
FR2338M
FR2338M FR904234A FR904234A FR2338M FR 2338 M FR2338 M FR 2338M FR 904234 A FR904234 A FR 904234A FR 904234 A FR904234 A FR 904234A FR 2338 M FR2338 M FR 2338M
Authority
FR
France
Prior art keywords
headaches
treatment
intended
vascular origin
new remedies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR904234A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unimed Inc
Original Assignee
Unimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unimed Inc filed Critical Unimed Inc
Application granted granted Critical
Publication of FR2338M publication Critical patent/FR2338M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR904234A 1961-07-17 1962-07-17 Nouveaux remedes destinés notamment au traitement des céphalées d'origine vasculaire. Expired FR2338M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US124362A US3149034A (en) 1961-07-17 1961-07-17 Method of relieving pain with (pyridyllower alkyl)-amines

Publications (1)

Publication Number Publication Date
FR2338M true FR2338M (fr) 1964-02-17

Family

ID=22414411

Family Applications (1)

Application Number Title Priority Date Filing Date
FR904234A Expired FR2338M (fr) 1961-07-17 1962-07-17 Nouveaux remedes destinés notamment au traitement des céphalées d'origine vasculaire.

Country Status (3)

Country Link
US (1) US3149034A (fr)
FR (1) FR2338M (fr)
GB (1) GB945095A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165376A (en) * 1971-01-29 1979-08-21 Lake Shore Roentgenology, Ltd. Treatment of the acute after-effects resulting from alcohol ingestion
SE464275B (sv) * 1989-07-31 1991-04-08 Aagerup Bengt Ny anvaendning av beta-receptorblockerare foer beredning av ett preparat verksamt mot menieres sjukdom
DK2293794T3 (da) 2008-05-27 2013-08-19 Univ Melbourne Fremgangsmåde til behandling af pattedyr med dysfunktioner af det eustakiske rør

Also Published As

Publication number Publication date
GB945095A (en) 1963-12-23
US3149034A (en) 1964-09-15

Similar Documents

Publication Publication Date Title
FR2338M (fr) Nouveaux remedes destinés notamment au traitement des céphalées d'origine vasculaire.
FR1336M (fr) Médicament anti-inflammatoire et hémostatique, son utilisation comme adjuvant au traitement des infections et compositions thérapeutiques constituées en vue d'une telle utilisation.
BE612141Q (fr) Nouveaux médicaments notamment pour le traitement des spasmes d'origine coronaire.
FR335M (fr) Nouveaux médicaments stéroides hydroxylés notamment pour le traitement des spasmes d'origine coronaire.
FR3419M (fr) Nouveaux médicaments notamment pour le traitement des états neuro-dépressifs et des psychoses d'anxiété.
FR1187M (fr) Nouveau médicament notamment pour le traitement des manifestations inflammatoires d'origine rhumatismale arthritique ou infectieuse.
FR1783M (fr) Formes stabilisées des diméthylcarboxy-alkylsulfonium utilisées, notamment, pour le traitement des affections hépatiques et vasculaires.
FR151M (fr) Nouveau médicament notamment pour le traitement des états neuro-dépressifs et des psychoses d'anxiété.
FR2778M (fr) Nouveaux médicaments notamment pour le traitement des spasmes d'origine coronarienne, vasculaire ou viscérale.
FR1764M (fr) Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne ou viscérale.
BE616479A (fr) Agents de traitement des spasmes d'origine vasculaire
FR1508M (fr) Nouveau médicament notamment pour le traitment des spasmes d'origine vasculaire.
FR1982M (fr) Nouvelles alcanamides-hydrazines n-substituées, utilisables notamment dans le traitement des infections staphylococciques rebelles.
FR1334211A (fr) Composition destinée au traitement des vins
FR1635M (fr) Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne.
FR1141M (fr) Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne.
FR1804M (fr) Nouveau médicament notamment pour le traitement des infections d'origine microbienne.
FR1729M (fr) Nouveau médicament notamment pour le traitement des manifestations inflammatoires et douloureuses.
FR1598M (fr) Nouveau médicament notamment pour le traitement des spasmes d'origine vasculaire, coronarienne ou viscérale.
FR1699M (fr) Nouveau médicament notamment pour le traitement des spasmes d'origine vasculaire et viscérale.
FR56F (fr) Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne ou vasculaire.
FR2053M (fr) Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne ou vasculaire.
FR1512M (fr) Nouveau médicament notamment pour le traitement de l'hypertension artérielle.
FR1466M (fr) Nouveau médicament notamment pour le traitement de l'hypertension artérielle.
FR1407M (fr) Nouveau médicament notamment pour le traitement des spasmes d'origine vasculaire.